Filed: 2026-04-22 AccNo: 0001477384-26-000004 Size: 29 KB
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - Orwin John A
Filed:
2026-04-22
AccNo:
0001477384-26-000005
Size:
25 KB
发布时间04/22 22:35 UTC
首次发现04/22 22:38 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 454 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001477384-26-000005
Filing Date: 2026-04-22
Accepted: 2026-04-22 18:35:46
Documents: 1
Period of Report: 2026-04-20
ANAPTYSBIO, INC ( Issuer ) CIK : 0001370053 (see all company filings) EIN. : 203828755 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | form4-04222026_100442.xml | 4 | 24352
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇